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on;ld%dk p- namvd by lnwlve bhxss. 
Bac~und. lkprrssrd fdtbrg rates measured nonlnv~slvety 
have been asaocfated with diastoftc dysftmcdou, sprrlltrally ab 
uonual relax&o of the left veotrkle. Tbrre is a reversel of ttwr4 
tbv$ tWng rates after sdo6tdttratton of eakium cbunnel 
Melkods. Dofqter &ornrdtogrepb!e meoruremenav of peaa 
6igttg rata were made and invmive high MeUty manumeter. 
oi&mnil(O.1 mgiltg body mtgbt) io 20pttmtsdthc~ 
artery dtsevsv who bad au ejection fruettoo >4tt% uud decmwd 
pnu Ruing rates. 
Resrdls. Verapamil catwd sigohicuot brereavea in the prak 
Rlllog rate, as measured by earty transmttral (El Row veltity, 
rr0la 0.57 * 0.16 m/s to 0.77 * 0.15 m/s tp < O.Ol), bnliiting 
reversut c6 decrwetl peak eing rates. Concoudtuotly, left veto 
trkular emldiastogc prwure tucrwvrd from 18.0 f 7.7 mm Ha 
to 24.1 t 9.0 rtuu tfa tp < 0.002). the tbtte eonvtsnt or re~tit& 
tw variabk, witb an overati siguiennt Inew from 46.8 t 
10.4 nu to 63.1 * 14.6 ms (p = 0.01). 
Cooclustonr. Verupwdl cdmintvtere6 intraveaouvly produced 
revmmldllccrwdpvaktillllratesinpatientswithnroosry 
artery diwavv and mrvml vmtrkulm function. However, there 
Aboonnalities of systolic function are frequently present in 
diseases of the heart, for which a growing number of 
therapeutic modalities have become available. Abnormal 
diastolic function also contributes substantially to the patho- 
physiology of various cardiac disorders ti,Z). As many as 
one third of patients with congestive heart failure have 
normal systolic function; thus, their symptoms are attributed 
to diastolic dysfunction (3). 
Currently, there is no accopled treatment for diastolic 
dysfunction. Diuretic drugs may decrease left ventricular 
ti!iing pressures and relieve symptoms of pulmonary conges- 
tion, but this may he at the expense of a decrease in forward 
cardiac output. Inotropic agents or afterload reduction may 
worsen the underlying pathophysiologic process in Select 
subsets ofpatients (4). A theoretic benefit of calcium channel 
blockers iI that these agents reduce cylosolic calcium, and 
thus may lessen the abnormalities of mywardial relaxation 
that contribute to abnormal diastolic filling of the heart (5,6). 
Low peaa filling rates measured noninvasively have been 
associated with abnormalities of ventricular relaxation (7-9). 
Clinical studies have demonstrated a reversal of abnormally 
low peak filling rates by calcium channel blockers in certain 
diseases f10.11). On the basis of these studies, it was 
proposed that calcium channel blockers may be useful in the 
treatment of diastolic dysfunction, speciftcally abnormalities 
of ventricular relaxation (12,23). 
However, the “normalirntion” of low peak tighrg rates 
by calcium chanuel blockers does not necessarily indicate 
improvement in ventricular relaxation because peak filling 
rates are influenced by many factors (7-9). Also, the results 
of studies limited to a particular subset of patients with a 
certain type of diastolic dysfunction should not be extraf!+ 
bated to all patients with diastolic abnormaiities. The obser- 
vation of elevation of diastolic tilling pressures despite a 
reversal of low peak filling rates atter administration of 
calcium channel blockers prompted us to study prospec- 
lively the immediate effect of calcium channel blockade on 
both invasive and noninvasive variables of diastolic filling of 
the kfi venlricle. 
Methods 
Our study group consisted of patients who were seen 
between October 195% and lune 1991 in the cardiac cathe- 
terization laboratory for clinically tndicated diagnostic an- 
giogmphy of the coronary arteries. Doppler echocardiogra- 
phy was performed immediately before the catheterization 
procedure. Patients were included in the study if they had a 
ratio of earlv ttansmitral Row velocitv to atrial Row velocitv 
(E/A ratio) 21.0; normal sinus rhythm, a heart rate of 50 & 
%J beatslmin and a normal QRS width: did not have valvular 
heart disease; were not being treated with calcium channel 
blockers. and had normal or only mildly depressed systolic 
function with an eiection fraction ~40%. Patients with 
unstable angina or -acute myoardial infarction were ex- 
cluded. Twenty patients met the criteria and were included 
in our study, which was approved by the Mayo Clinic 
Institutional Review Board. informed consent was obtained 
from patients before their participation. 
All patients took nothing by mouth after midnight before 
cardiac catheterization. The mean interval from the onset of 
fasting to catheterization was 10.5 ? 2.4 h (range 7.4 to 
16.4 h). All patients received SO to 100 ml of 0.45 normal 
saline solution in the preparation room before the procedure 
was txgttn. 
At the start ofeach procedure, before angiography. a high 
fidelity, manometer-tipped catheter was placed retrofzadelv 
acrosr the aortic va& in the left veniricle and 2%iI c 
of heparin was given intravenously. A 3F high fidelity 
manometer-tipped catheter inserted through at SF Ruid- 
filled catheter was used. The manometer-tipped catheter was 
calibrated to atmospheric pressure before insertion and 
balanced lo the fluid-filled catheter after both were inserted 
into the left ventricle. The catheters were placed at the base 
of the heart to avoid ventricular ectopic activity. 
Pulse+ wave Doppler recordings of the mitral flow veloc- 
ities were obtained with the sample volume placed near the 
tips of the mitral valve leaflets as previously described (9). 
Recordings were made of the simultaneous Doppler tracings. 
high fidelity pressures and elecIrocardiogtam~ (ECGs) on a 
strip chart recording at 100 mm/s at held end-expiration. 
Each recording was made continuously for at least 30 s with 
5 consecutive beats al held end-expiration. 
AtIer the baseline recordings were obtained, verapamil 
(0.1 m&g body weight) was given intravenously over a 
tmin period. After a 5-min interval, to allow vetapamil to 
attain its maximal effect (14). tneasurentents of mitral Row 
velocities and high fidelity left ventricular pressures were 
again made on strip chart recordings. Three consecutive 
c&les of both the-Doppler flow v;locities and the high 
iidelitv messttres at baseline and after administration of 
ver&& were diitized at 3-ms intervals with a Jandel 
digitizing tablet. The Doppler and pressure data were taken 
from the strip chart recordings to ensure that the same 
cardiac cycle was analyzed. The Doppler variables obtained 
included the peak E velocity, the peak velocity at &ial 
contraction and the deceleration time (9). The deceleration 
time was taken as the time fmm peak E velocity to an 
extrapolation of the deceleration of Row to baseline (Fig. 1). 
The hemodynamic measurements included peak positive 
Figure 1. Left vwtticular high-fidelity pressure superimposed on 
mitral Row velocity curve. TN, is the fime comtaat of relaxation. 
The mitral Row velocity curve is analyzed in terns of peak initial 
transmmal El Row velwity Ws). velocity at atrial contraction (A 
velocity, ,tis; and decelerxicm time COT,. 
first derivative of left ventricular pressure (dP/dt), peaL 
systolic pressure, minimal diastolic pressure, ventricular 
end-diastolic pressure (taken at the peak of the R wave) and 
tau IITI the time constant of relaxation). Tau was calculated 
bv the rimi:o:adthmic model: P,,, = PK=‘. where P is 
p&sure. t is &tte, PO is eguiva.& to gt, (pressure at the 
beeinnine of isovolumetric relaxation) when a true exwnen- 
tiai de& is approximated starting & peak oegativ; dP/dt 
and e is the base for the natural loearithm. The P_ and T 
variables were estimated from a lit& least-qua& fit ott 
In P = -Vr + In P, (15). 
Two observers (A.J.T.. R.A.N.) measured the Lhwvler 
vatiaoles in blinded fashion and two observers (R.iS , 
R.A.N.) measured the hemodynamic and invasive variables 
in blinded fashion. An interob&ver mean percent dilTerence 
was then calculated to determine variability of the roeawe- 
merits. 
The interobserver tneatt percent variability for the Dop 
Br velocitv mea.suretnents was 1.4% for E velocity and 
i3.0% for d&eleralion time. The in:erobserver mean p&cent 
vatiahtlity for the nteaswement of tau was 8.6%. 
The mean value and SD were calculated for each vari- 
able. A two-sided paired t test was used to detenttine 
whether there was any dilTerence in the variables by com 
paring the baseline state with that after administration of 
verapamil. A linear regression analysis was used to compare 
the percent change from before to after administration of 
verapamil between different variables. A sig&xmce level 
was set at p < 0.05. 
Study potientr. We studied 20 patients (16 men and 2 
women) with a mean aa of 62 years (ramze 47 to &I) and B 
mean body surface arei of 2.0 -+ 0.2 nt’ (tanpe 1.7 to 2.4). 
The mean eiection fraction was 59 t I@% hanre 4@% to 
77%). Seven patients had discrete areas of‘re~onal wall 
motion abnormalities; the I3 other patients had no regional 
Table 1. EtSct of Yerapamil on Hemodynamic Measurements 
cnntral Yerammil 0 wue 
wall motion abnormalities. Eighteen of the patients had 
significant multivessel coronary artery disease (270% hunen 
diameter stenosis of at least two major arteries) and 3 of the 
18 had undergone coronary artery bypass grafting. Twc 
patients were referred for chest pain but had only mild 
coronary artery disease. Ten patients had a history of 
hypertension. Of these IO patients, 2 had echocnrdiographic 
evidence of mild left ventricular hypertrophy. Before enter- 
ing our stutiy, eight patients were treated with long-acting 
nitrates and eight with low dose beta-adrenergic blocking 
agents (less than an equivalent of 80 “g/day of propranolol). 
&ml rate and blmnl pressure. There was a significant 
decrease in peak systolic blood pressure (from 129 * 26 to 
119 i 19 mm Hg, p = 0.001) after verapamil was given 
(Table I). Although there was a trend toward a longer RR 
interval after administration of the drug, it was not signiti- 
cant (831 * I38 vs. 851 f 128 ms). 
Doppler mitral Row velocities. All baseline mitral flow 
velocity cmves had an E/A ratio <I in the control state, as 
required by the criteria for patient selection. The mean E 
velocity was 0.57 f 0.16 mls, and the mean A velocity was 
0.63 f I8 m/s, with a deceleration time of 260 + M) ms (Table 
2). After administration of verapamil, E velocity increased 
significantly to 0.77 ? 0.15 m/s (pi 0.001) (Fig. 2 and 3) and 
the deceleration time shortened to 190 + 40 ms (a < 0.001). 
There was no sianificaot change in the A velo&y (0.64 & 
O.i9m/S). - 
LeR ventricular pressure& Minimal left ventricular dia- 
stolic pressure and the end-diastolic left ventricular pressure 
increased significantly after the administration of verapamil 
(9.1 + 4.7 vs. II.4 2 5.3 mm Hg [p = 0.0371 and 18.0 + 7.7 
vs. 24.1 f 9.0 mm Hg [p < O.lWl], respectively) (Table I, 
Tabte 1. EEect of Verapamil on Doppler 
Echocardio~phic Findings 
variable CO”U0l Yrrwmil n wue 
Fig. 4). There was a significant decrease in peak positive 
dP/dt (from 1,930 f 640 to 1,630 c 550 mm Hgis, p = 0X05), 
indicating a depression in systolic function. 
The effect of verapamil on tau is shown in Figures 2 and 
5. The responses varied, with I3 patients demonstrating an 
increase and the 7 others showing no change or a decrease in 
tau. Overall, the increase in tau (from 46 + IO to 53 t I5 ms) 
was signiiicant (p = 0.01). 
In comparing the 7 patients with discrete regional wall 
motion abnormalities with the t3 patients who had no 
regional wall motion abnormalities, there was no significant 
difference in the percent change in tau before and after 
administration of verapamil. Of the seven patients who 
showed no change or a decrease in tau after administration 
of verapamil, only one had rest regional wall abnormalities. 
In comparing the 8 patients who were treated with low 
dose beta-blockers with the 14 patients who were not so 
treated, the percent change in either left ventricular end- 
diastolic pressure or tau before and after administration of 
verapamil was not significant. 
Relation of the Doppler and hemalynamic variables. The 
percent changes in E velocity after the intravenous admin- 
istration of verapamil were compared with the changes in 
hemodynamic variables. The changes in the time constant of 
relaxation were plotted against the changes in E velocity 
(Fig. 6). There was no relation between these variables 
@ = NS). However, there was a linear correlation be- 
tween the change in let? ventricular end-diastolic pressure 
and the change in E velocity (Fig. 7). This was a direct 
correlation, with a greater change in E velocity correlating 
with a greater change in left ventricular end-diastolic pres- 
sure (p < 0.05). 
Revioussludiesan~ta(~ium~on~filling 
rates. There is growing interest in the use of calcium chan- 
nel blockers for the treatment of abnormalities of diastolic 
function (12.13). In hwettroDhic cardiomvoaathv. the major 
abnormaiity is diastoiie dysfunction due to iela&d m&w- 
dial relaxation and decreased early filling (16). It has been 
suggested that he abnormal hemodynamics of this disease 
are due to an increase in intracellular calcium (6). which 
cawes an increase in myocardial contraction and a delay in 
myocardial relaxation (17). Improvement in the rate of 
relaxation of the left ventricle has been reported after 
administration ofcalciumchannel blocking agents in patients 
with hypertrophic cardiomyopathy and has been docu- 
mented with measurements made with invasive procedures. 
The measurements indicated imDrovement in ventricular 
relaxation as well as an increask in early diastolic tilling 
(5.18.19L The exam mode of action of calcium channel 
blockadk in these patients is not known. but it probably 
involves inhibition of calcium intltu into muscle cells. which 
results in a decrease in cytosolic calcium (5,18,19). 
Several recent studies examined the effect of calcium 
Pttre 2. Simultaneous mitral Row velocities and 
pressure curveS from two patients (upper and 
towrj before and after intravenous administra- 
lion of verapamil (0.1 mikg). Uppr and tower 
left, Control tracings. tJpp(r and loner right, 
Tracings after verapamil. edp = end-diastolic 
pressure; LVEDP = left ventriFularend-diartolic 
PAIEUA: other abbreviations as in Figure I 
channel blockade on peak tilling rates in bypwtrophic car- 
diomyopathy and other heart diseases. Peak filling rates 
have been proposed as a noninvasive method to assess 
diastolic filling of the left ventricle. With the use of mdio- 
nuclide angio-gsaphy, digitized M-mode echocardiography 
or oappler echocardiagmphy, decreased peak filling rates 
were demonstrated in a large proportion of patients with 
d&rent diseases, such as hypertrophic cardiomyopathy 
(20). hvwtlenaion (21) and coronaw artery disease (22-24). 
P&&&ion of relaxation results ina de&e of peak filling 
rates (7-9); therefore. decreased peak filling rams have been 
interpreted to indicate an abnormality of relaxation (9). Also, 
with measuremettts obtained by these noninvasive methods, 
several studies documented a reversal of the decreased peak 
filling rates by calcium channel blockers in acute and chronic 
conditions. This reversal has been shown in patients with 
Figure 3. Plot of changes in early trammitral 65) Row velocity on 
mitral Row velocity curve before (Control> and after intraxnous 
administration of vempamil (0.1 &kg). 
hypertrophic cardiomyopathy (20.24-27). hypertension 
(I I.281 and coronary arterv disease (10.29). The implication 
is that calcium channel blockade improves abn&nal dia- 
stolic relaxation and. as a result. there has been widespread 
clinical use of calcium channel blockers to treat all types of 
patients with presumed diastolic dysfunction. 
A major misconception has emergedfrom these studies. 
It is based on the assumption that a simplistic measurement, 
such as peak filling rate, can he used to determine the etTect 
of an intervention or drug on the rate of ventricular relax- 
ation of the left ventricle. Although a depressed peak filling 
rate has been associated with an abnormality of relaxation 
(9). a reversal of such depressed peak filling rates to “nor- 
mal” levels does not necessarily indicate an improvement in 
relaxation (7.9). The improvement in diastolic filling by 
calcium channel blockers in patients with hypertrophic car- 
Figure I. Plot of :i;ne constant of relaxation (TALlI before (Control) 
and after intravenous administration of verapamil (0. I m#kg). 
diomyapathy, which was documented by the mere sophisti- 
cated invasive measurements (5.18,19), should not necessar- 
ily be extrapolated to other disease states. 
Sigoi6cance of decreased tilling rates in Present study. In 
our study, short-term administration of verapamil caused a 
uniform increase in the law peak filling rates in patients with 
coronary artery disease. This “nomtalization” ofpeak filling 
rates has been documented by others in patients with corc- 
nary artery disease and has been interpreted as improving 
relaxation abnormalities. However, Peak filling rates are 
dependent on other contributing factors, including ventricu- 
lar compliance, atrial compliance, ventricular function and, 
mwt important, the driving pressure across the mitral valve 
(7-9). Verapamil had a variable effect on tau, which is 
currently accepted as the standard measurement for myo- 
cardial relaxation in humans, and there was a worsening of 
relaxation in the majority of patients. This effect was con- 
firmed by another study (30). The change in peak tilling rate 
correlated best with an increase in left ventricular end- 
diastolic pressure, an important determinant of the driving 
pressure across the mitral valve. The increase in filling 
pressures was noted in the studies that initially examined the 
effect of verapamil(l4,31.32) and was thought to be due to a 
decrease in systolic cont-wtility. with an increase in end- 
Figore 6. Plot of change in time constant of relaxation (TN) 
against change in early trammitral (E) Row velocity by Doppler 
echocardiography after intravenous administration of verapamil 
(0.1 mdks). 
. 
diastolic volume (30-32). This view is consistent with the 
decrease in dP/dt noted in our study. Thus, the reversal of 
decreased peak filling rates in our group of patients may 
indicate a detrimental effect on overall cardiac function 
rather then a beneficial effect on relaxation. 
Mvocardial retaxation is a complicated process that is 
dependent not only on muscle inac&ion but also cm load 
and uniformitv of relaxation in both time and smxe (33.34). 
Thus, many &npeting forces effect the response of relax- 
ation to calcium channel blockers in various diseases. Relief 
of ischemia (35,36), reduction of afterload (23) and more 
synchronous relaxation (26.37) are all b=eneficial eliects that 
calcium channel blockers have on myecardial relaxation. 
The prolongation of relaxation with verapamil seen in some 
patients in our study is consistent with the known elTects of 
altered transcellular calcium flux in myocardial cells, iso- 
lated papillary muscle and intact heart (38-40). Because 
cytosolic-ionized calcium is necessary for sarcoplasmic 
membrane adenosine triphosphatase for calcium seqttestra- 
tion and inactivation, a decrease in transcellular calcium flux 
diminishes inactivation-dependent relaxation in parallel with 
a decrease in contraction. Therefore, whether worsening of 
relaxation occurs depends on the degree of decrease in 
contractility caused by calcium channel blockade (38,411. 
This may explain the improvement in relaxation seen in 
patients with coronary artery disease who are prescribed 
bther calcium channel blockers such as diltiazem (42,431 and 
nifedipine (44). These drugs have a less depressive effect on 
myocardial function than verapamil does (38). 
The overall improvement in relaxation and decrease in 
left ventrictdar end-diastolic pressure that occur with cal- 
cium channel blockade in patients with hyperirophic cardi* 
myopathy may he related to the high concentration of 
intracellular calcium and hyperdynamic contractility, which 
suppress the negative inotropic effect (5,18,19), 
Liiitalions of the sludv. A maim limitation of our studv 
is the heterogeneity of th; study &up, that is, patients with 
coronary artery disease and dscreaseu peak filling rates. 
This group consisted of patients with a tide variability in the 
severity of coronary artery disease and probably in rhe 
degree of myocardial ischemia or fibrosis. There was a wide 
range of tau and left ventricular diastolic pressures at base- 
line. Nonetheless, these patients are typical of the patients 
who constitute a large percentage of a medlcal practice and 
who would be considered for treatment of diastolic dysfunc- 
tion. 
The small number of patients precludes analysis of pa- 
tient subsets. lo patients with ischemia-induced wall motion 
abnormalities. verapamil could potentially improve the rate 
of ventricular relaxatwn by decreasing ischemia. resulting in 
more synchronous relaxation. The effect of vcrapamil on 
patients with documented leit ventricular hypenrophy might 
differ from the effect on those with normal left vcntricu!ar 
mass. The study herein was not designed to examine these 
subgroups and, thus, the number of patients in these sub- 
groups was toa small to allow an analysis of this type. 
_ __ 
optimal method for measuring tau is controversial and has 
inherent limitations (45). Tao is dependent on both afterload 
and oreload (40.45). both of which were affected bv wra- 
p&l. Meas&&oents were not made of the passivkelasdc 
properties of the heart by using pressure-volume or stress- 
strain relations. These properties also contribute to diastolic 
filling of the heart (12.45). However, previous investigations 
found that calcium channel blockers do not alter either the 
intrinsic distension of the cardiac chamber or muscle stiff- 
ness (18.41.46.47). Finally. although there was no statistical 
difference in the hemod&oic changes seen between pa- 
tients given and not given the low dose beta-blockers, the 
coexistent medications may have exacerbated the negative 
inotropic response to verapamil (48.49). However, it was 
thought that patients who were taking low dose beta- 
blockers should be studied because venpamil is frequently 
used in patients in whom uxatment for diastolic dysfunction 
is considered. 
Implicaliom Our results should no, be misconstrued IO 
mean that verapamil is uniformly detrimental for all patients 
with coronary artery disease and abnormalities of ventricu- 
lar relaxation. In some patients. the increase in left ventric- 
ular end-diastolic pressore may actually be beneficial in 
terms of improving~fonwd cardiac outpot by means of the 
Starlinn mechanism 00). Long-term ingestion of verwmil 
may h&e a di&xent effect o; diastolic filling than that of 
isolated inttwenous admit&ration of venpamil (50. Relief 
from symptoms and improvement in exercise tolerance may 
still occur despite the detrimental changes that we have 
demonstrated (52). The purpose of our stody was to indicate 
that verapamil has a detrimental e5ect on left ventricular 
relaxation and end-diastolic pressures. despite a uniform 
“improvement” in peak filling rates, as measured by oonin- 
vasive methods. Thus, peak filling rates alone should not be 
used to assa changes in the rate of ventricular relaxation. 
because pxadoxic deterioration may be accuniog. Future 
stud& lhat eramix the long-term effects ofcalciumchaonel 
blockers on a large number of patients sod that use invasive 
and clinical variables are required before the mutine empiric 
use of these drugs can be recommended. 
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